Viewpoint

Nutrition Bulletin

Volumn 21, Issue 3, 1996, Pages 204-208

  Fuller, Roy ^a  

^a Ryeish Green   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85040478053     PISSN: 14719827     EISSN: 14673010     Source Type: Journal    
DOI: 10.1111/j.1467-3010.1996.tb00854.x     Document Type: Article

References (30)

1. Vollaard EJ, Claesner HAL. Colonization resistance. Antimicrob Ag Chemother 1994; 38: 409–414.
2. Fuller R ed. Probiotics - The Scientific Basis. London: Chapman & Hall, 1992.
3. Miller D. Yoghurt: how healthy is it?Which April 1993, 38–41.
4. Hamilton-Miller JMT, Shah S, Smith CT. Probiotic’ remedies are not what they seem. Br Med J 1996; 312: 55–56.
5. Lee Y-K, Salminen S. The coming of age of probiotics. Trends Fd Sci Technol 1995; 6: 241–245.
6. Katelaris PH, Salam I, Farthing MJG. Lactobacilli to prevent traveler's diarrhea N Engl J Med 1995; 333:1360–1361.
7. Stansbridge EM, Walker V, Hall MA et al. Effects of feeding premature infants with Lactobacillus GG on gut fermentation. Arch Dis Child 1993; 69:488–492.
8. Saavedra JM, Bauman NA, Oung I, Perman JA, Yolken RH. Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus. Lancet 1994; 344: 1046–1049.
9. Bellomo G, Mangiagle A, Nicastro L, Frigerio G. A controlled double-blind study of SF68 strain as a new biological preparation for the treatment of diarrhoea in pediatrics. Curr Ther Res 1980; 28:927–936.
10. Borody TJ, George L, Andrews P et al. Bowel flora alteration: a potential cure for inflammatory bowel disease and irritable bowel syndrome Med J-Australia 1989; 150: 604.
11. Andrews PJ, Barnes P, Borody TJ. Chronic constipation reversed by restoration of bowel flora Eur J Gastroenterol Hepatol 1992; 4: 245–247.
12. Andrews PJ, Borody TJ. Putting back the bugs’: bacterial treatment relieves chronic constipation and symptoms of irritable bowel syndrome. Med J Australia 1992; 159:32: 633–634.
13. Fuller R. Probiotics in human medicine. Gut 1991; 32: 439–442.
14. Tomioka H, Sato K, Saito H. Effect of ofloxacin combined with Lactobacillus casei against Mycobacterium fortuitum infection induced in mice. Antimicrob Ag Chemother 1990; 34: 632–636.
15. Smoragiewicz W, Bielecka M, Babuchowski A, Boutard A, Dubeau H. 1993. Les probiotiques. Canad J Microbiol 1993: 39: 1089–1095.
16. Agerbaeck M, Gerdes U, Richelsen B. Hypocholesterolaemic effect of a new fermented milk product in healthy middle-aged men. Eur J Clin Nutr 1995; 49:346–352.
17. Jett BD, Huycke MM, Gilmore MS. Virulence of enterococci. Clin Microbiol Rev 1994; 7: 462–478.
18. Alcid DV, Troke M, Anoszewski S, John JF. Probiotics as a source of Enterococcus faecium. Abs Inf Dis Soc Amer Meet 1994; pp 123.
19. Jesudason MV, Hentges DJ, Pongpech P. Colonisation of mice by Campylobacter jejuni Infect Immun 1989; 57: 2279–2282.
20. Bohnhoff N, Drake BL, Miller CP. Effect of streptomycin on susceptibility of the intestinal tract to experimental salmonella infection. Proc Soc Exp Biol Med 1954; 86; 132–137.
21. Schwass A, Sjolin S, Trottestam U, Aransson B. Relapsing Clostridium difficile enterocolitis cured by rectal infusion of normal faeces. Scand J Infect Dis 1984; 16:211–215.
22. Tannock GW. Microbiology of the gastrointestinal tract in relation to lactic acid bacteria Intern Dairy J 1995; 4: 1059–1070.
23. Kolars J C, Levitt M D, Aouji M, Savaino D A. Yoghurt - an auto digesting source of lactose, New Engl J Med 1984; 310: 1–3.
24. Martini MC, Kukielka D, Savaiano DA. Lactose digestion from yoghurt: influence of a meal and additional lactose. Am J Clin Nutr 1991; 53: 1253–1258.
25. Perdigon G, Nader de Macias ME, Alvarez S et al. Effect of a mixture of Lactobacillus casel and Lactobacillus acidophilus administered orally on the immune system in mice. J Food Prot 1986; 49:986–989.
26. De Simone C, Famularo G, Jirillo E et al. Rethinking the role of probiotics for the prevention and treatment of enteropathies. In: Probiotics, Prospects of use in Opportunistic infections. Fuller R., Heidt P J, Rusch V, van der Waaij D eds. Proceedings of the 8th Old Herborn University Seminar 1994 June 27–29; Herborn. Institute for Microbiology and Biochemistry, Herborn - Dill, 1995: 67–80.
27. Wunderlich PF, Braun I, Fumagalli I et al. Double-blind report on the efficacy of lactic acid-producing enterococcus SF68 in the prevention of antibiotic-associated diarrhoea and in the treatment of acute diarrhea. J Int Med Res 1989; 17: 333–338.
28. McFarland L, Surawicz CM, Greenberg RN et al. Prevention of ß-lactam-associated diarrhoea by Saccharomyces boulardii compared with placebo. Am J Gastrenterol 1995; 90: 439–448.
29. Lauland S. Commercial aspects of formulation, production and marketing of probiotic products. In Human Health: the contribution of microorganisms. Gibson SAW ed. London: Springer-Verlag 1994, 159–173.
30. Sanders ME. Summary of conclusions from consensus panel of experts on health attributes of lactic cultures: significance to fluid milk products containing cultures. J Dairy Sci 1993; 76: 1819–1820.